Pathology for Discovery, Development and Delivery of Diagnostics platform
Published: 18 July 2018
The Glasgow Molecular Pathology Node was established to transform the management of cancer and chronic disease by accelerating biomedical research, high quality healthcare provision and economic growth.
The Glasgow Molecular Pathology Node was established to transform the management of cancer and chronic disease by accelerating biomedical research, high quality healthcare provision and economic growth. Central to this vision is the development of a platform that provides integrated access to biorepository, pathology, molecular pathology/ diagnostics, informatics and health economics to support the development and implementation of novel diagnostics.
The PD4 platform (Pathology for Discovery, Development and Delivery of Diagnostics) is embedded within the Laboratory Medicine Building at the Queen Elizabeth University Hospital enabling costs and cultures to be shared and development pipeline to be firmly rooted in clinical practice and widely translatable.
The PD4 platform enabled by the Glasgow Molecular Pathology Node includes:
• NHSGGC biorepository activities for tissue acquisition and handling
• Clinical and biomedical scientists and pathologist contributions
• Clinical informatics/developer including annotation of research tissues within NHSGGC SafeHaven
• Research scientists within genomics and cardiovascular science
• Research informatics within genomics and polyomics
• Health Economics
This platform can be accessed by researchers and industry that are at different stages in the development pathway including discovery, assay development, validation, evaluation and translation into clinical use. The PD4 provides opportunities for engagement for researchers and industry to facilitate molecular diagnostics development and associated technologies and software enabling a range of outcomes including: new molecular diagnostics for clinical trials and clinical practice; enhance of molecular diagnostic and pathology services; improved efficiency and cost savings and transfer of expertise and assays across the Node network.
Download a summary of the PD4 platform along with an example use case (PRECISIONPanc) below.
First published: 18 July 2018